Supplied in a sterile, single-use, 3 mL glass vial
Indications and Usage:
Indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients <65 years of age.
Up to 1 year after production date. Refrigeration required
Side Effects and Contraindications:
AonabotulinumotoxinA is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any ingredient in the formulation. The most frequently reported adverse events (≥2%) are nasopharyngitis, headache, injection site pain, injection site reaction, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis and nausea.
Medicis, The Dermatology Company